07:00 , Jul 26, 2010 |  BC Week In Review  |  Company News

Amdipharm International Ltd., Invida sales and marketing update

Amdipharm granted Invida exclusive rights in eight Asian territories to commercialize nine branded generics, including Neomercazole carbimazole for hyperthyroidism. Invida is responsible for obtaining regulatory approval, if necessary, in the territories, which include Thailand,...